Zikani Therapeutics, Inc. — Form D

Zikani Therapeutics, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-13. The offering totals $20.0M, of which $12.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Markus GoebelDirectorSunnyvale, CA
Vikas GoyalDirectorBoston, MA
Anja HarmeierDirectorBoston, MA
ANDREW MYERSDirectorSAN FRANCISCO, CA
Raj ParekhDirectorWaltham, MA
HENRY SKINNERDirectorSAN DIEGO, CA
Mary SzelaDirectorWestminster, CO
Christopher ViehbacherDirectorCambridge, MA
Joseph ZakrzewskiDirectorWatertown, MA
Edward MascioliExecutive OfficerWatertown, MA
Lawrence MillerDirectorAston, PA
Lawrence MillerExecutive OfficerAston, PA
Sumit AggarwalDirectorWatertown, MA
Sumit AggarwalExecutive OfficerWatertown, MA
Christopher A ViehbacherDirectorWatertown, MA
Raj B Parekh, Ph.D.DirectorWatertown, MA
Andrew G LittlehaleExecutive OfficerWATERTOWN, MA
Henry G SkinnerDirectorWATERTOWN, MA
Monique G SciersingDirectorWATERTOWN, MA
Raj G ParekhDirectorWATERTOWN, MA
Andrew G MyersDirectorWATERTOWN, MA
Vikas G GoyalDirectorWATERTOWN, MA
Fereydoun G FirouzDirectorWATERTOWN, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2020-04-16D$7.5M$7.5M
2016-04-29D/A$27.8M$12.2M
2015-02-25D$22.3M$8.2M

More